Description: - A unique collection of 4080 compounds for high-throughput screening and high-content screening, an effective tool for drug repurposing and anti-COVID-19 drug development- Some compounds have been marketed and approved by FDA, EMA, NMPA and other authorities, and most have passed Phase I clinical studies- ReFRAME Related Library has excellent structural diversity through cluster analysis of structural diversity, including 2698 clusters (similarity between different clusters <70%), with an average of 1.2 compounds per cluster.- Covering multiple research areas: oncology, cardiovascular drugs, anti-inflammatory/immune, neurological drugs, respiratory drugs, etc.- Diverse targets, including 5-HT Receptor, Sodium Channel, p38 MAPK, PI3K, MEK, etc.- Detailed specifications, compound structure, target information, disease indication information, activity description, etc.- NMR, HPLC/LCMS and other detection techniques to ensure correct structure and high purity of the product and reduce false positives.
English
Deutsch
